ANCA-Associated Vasculitis with Kidney Involvement at a Tertiary Care Centre: A Retrospective Case Series Characterising Disease Patterns, Histopathological Findings, and Clinical Outcomes (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0651; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Induction therapy included cyclophosphamide alone (n=12), rituximab alone (n=7), and combination therapy (n=6). Biopsy-guided risk stratification using validated tools such as the Berden classification and BVAS/VDI scoring systems may improve prognostication and management. These findings support the need for larger prospective multicentre studies across the region."
Clinical data • Retrospective data • ANCA Vasculitis • Chronic Kidney Disease • Eosinophilic Granulomatosis With Polyangiitis • Glomerulonephritis • Immunology • Infectious Disease • Langerhans Cell Histiocytosis • Lupus Nephritis • Nephrology • Rare Diseases • Renal Disease • Vasculitis
|
|
Ziad Arabi; Junaid Iqbal; Abdulkarim Shayif Saeed; Abdullah Essam Almanea; Hussam Zaid Alorabi
|